The Epilepsy Therapy Project supports innovative research in both academic and industry settings through direct grants and investments. Learn about our programs and how the Epilepsy Therapy Project is supporting research and helping to advance new therapies.

New Therapy - Commercialization Grants / Apply for Grant Funding

The New Therapy - Commercialization Grants Program is a unique partnership between two leading epilepsy non-profit organizations, the Epilepsy Therapy Project and the Epilepsy Foundation. The mission of the New Therapy - Commercialization Grants Program is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. Funding is provided to academic and commercial groups worldwide. The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Preference will be given to proposals that already have a commercial partner engaged to assist with development, and to proposals that have committed or matched funding from a sponsoring institution, commercial partner or other third party source. Read more

Funding Portfolio

The Epilepsy Therapy Project directly supports promising new therapies and emerging epilepsy focused companies through research awards and equity investments. Review the list of funded projects and investments in this section. Read more

Other Sources of Funding

View the list of additional funding sources here. Read more